[1]
“Relooking at Nitrofurantoin as drug of choice for empiric treatment of community acquired uncomplicated urinary tract infections: An effective and economic treatment option”, Int Jour of Biomed Res, vol. 8, no. 6, pp. 320–324, Jun. 2017, doi: 10.7439/ijbr.v8i6.4180.